Iovance Biotherapeutics, Inc.
Remnant tumor infiltrating lymphocytes and methods of preparing and using the same

Last updated:

Abstract:

In some embodiments, methods of delivering a therapeutically effective amount of an expanded number of tumor infiltrating lymphocytes obtained from tumor remnants to a patient in need thereof, for the treatment of a cancer, are disclosed.

Status:
Grant
Type:

Utility

Filling date:

19 Feb 2021

Issue date:

11 Jan 2022